Kamphues, C., Lefevre, J. H., Wang, J., Amini, N., Beaugerie, L., Kuehn, F., Park, S. H., Andreatos, N., Lauscher, J. C., Enea, D., Lehmann, K. S., Peru, N., Weixler, B., Kirchgesner, J., Degro, C. E., Pozios, I., van Beekum, C. J., Schölch, S., Zambonin, D., Schineis, C., Loch, F. N., Geka, D., Theoxari, M., Wu, B., Wang, P., Antoniou, E., Pikoulis, E., Moussata, D., Theodoropoulos, G., Ouaissi, M., Seeliger, H., Inaba, Y., Scaringi, S., Reißfelder, C., Vilz, T. O., Lin, C., Yang, S., Beyer, K., Renz, B. W., Sasaki, K., Margonis, G. A., Svrcek, M., & Kreis, M. E. (2023). prognostic value of primary tumor sidedness in patients with non-metastatic IBD related CRC – Is it the exception to the rule?. Surgical oncology, 45, . http://access.bl.uk/ark:/81055/vdc_100170510443.0x00002d